Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

633 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group. Ferrante M, et al. Lancet. 2024 Dec 14;404(10470):2423-2436. doi: 10.1016/S0140-6736(24)01762-8. Epub 2024 Nov 21. Lancet. 2024. PMID: 39581202 Clinical Trial.
High-Yield Production of SiV-Doped Nanodiamonds for Spectroscopy and Sensing Applications.
Kromka A, Varga M, Aubrechtová Dragounová K, Babčenko O, Pfeifer R, Flatae AM, Sledz F, Akther F, Agio M, Potocký Š, Stehlík Š. Kromka A, et al. Among authors: varga m. ACS Appl Nano Mater. 2024 Oct 25;7(21):24766-24777. doi: 10.1021/acsanm.4c04676. eCollection 2024 Nov 8. ACS Appl Nano Mater. 2024. PMID: 39539806 Free PMC article.
Development of toxicity tests for Polyurethane foams.
Mallouhi J, Hornyák-Mester E, Varga M, Viskolcz B, Fiser B, Szőri-Dorogházi E. Mallouhi J, et al. Among authors: varga m. Heliyon. 2024 Sep 25;10(19):e38440. doi: 10.1016/j.heliyon.2024.e38440. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39403457 Free PMC article.
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempiński R, McGovern DPB, Ma C, Ritter TE, Targan S; ARTEMIS-UC Study Group. Sands BE, et al. N Engl J Med. 2024 Sep 26;391(12):1119-1129. doi: 10.1056/NEJMoa2314076. N Engl J Med. 2024. PMID: 39321363 Clinical Trial.
633 results